Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Regimens After LAMax LAAC Occlusion
NCT05761704Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Incidence of device-related thrombosis at 24 weeks and Incidence of stroke and transient ischemic attack at 24 weeks. Status: unknown.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05761704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761704.